We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,802 hedge funds and large institutions have $249B invested in Johnson & Johnson in 2024 Q2 according to their latest regulatory filings, with 162 funds opening new positions, 1,507 increasing their positions, 1,791 reducing their positions, and 154 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more call options, than puts

Call options by funds: $2.12B | Put options by funds: $1.78B

1.01% more ownership

Funds ownership: 69.87%70.88% (+1%)

5% more first-time investments, than exits

New positions opened: 162 | Existing positions closed: 154

1% less funds holding

Funds holding: 3,8493,802 (-47)

6% less capital invested

Capital invested by funds: $266B → $249B (-$16.5B)

16% less repeat investments, than reductions

Existing positions increased: 1,507 | Existing positions reduced: 1,791

19% less funds holding in top 10

Funds holding in top 10: 204165 (-39)

Holders
3,802
Holders Change
-47
Holders Change %
-1.22%
% of All Funds
54.9%
Holding in Top 10
165
Holding in Top 10 Change
-39
Holding in Top 10 Change %
-19.12%
% of All Funds
2.38%
New
162
Increased
1,507
Reduced
1,791
Closed
154
Calls
$2.12B
Puts
$1.78B
Net Calls
+$333M
Net Calls Change
-$99.1M
Name Holding Trade Value Shares
Change
Change in
Stake
NS
1151
NBC Securities
Alabama
$6.05M +$17.3K +116 +0.3%
CCT
1152
Capital City Trust
Florida
$6.02M -$182K -1,226 -3%
SCM
1153
Stonebridge Capital Management
California
$6M -$29.7K -200 -0.5%
CAM
1154
Costello Asset Management
Pennsylvania
$6M -$314K -2,114 -5%
SCA
1155
Stokes Capital Advisors
South Carolina
$6M -$673K -4,527 -10%
SL
1156
Sentry LLC
Tennessee
$5.99M -$149 -1 -0%
PCA
1157
Providence Capital Advisors
North Carolina
$5.98M +$669K +4,500 +12%
IF
1158
Insight Folios
North Carolina
$5.98M +$153K +1,026 +3%
BIC
1159
Beach Investment Counsel
Pennsylvania
$5.97M -$1.68M -11,320 -22%
FCT
1160
Family Capital Trust
Massachusetts
$5.97M -$4.02K -27 -0.1%
CFSG
1161
Community Financial Services Group
Vermont
$5.96M +$203K +1,367 +3%
BFG
1162
Berger Financial Group
Minnesota
$5.95M +$75.4K +507 +1%
CGH
1163
Crossmark Global Holdings
Texas
$5.93M +$120K +807 +2%
EM
1164
Excalibur Management
Massachusetts
$5.92M +$93.5K +629 +2%
CSPAM
1165
Cary Street Partners Asset Management
Virginia
$5.92M +$941K +6,324 +19%
NG
1166
Northstar Group
New York
$5.91M -$143K -964 -2%
CAL
1167
Capital Analysts LLC
Pennsylvania
$5.89M +$140K +942 +2%
FFWA
1168
FRG Family Wealth Advisors
Washington
$5.89M -$185K -1,246 -3%
GFS
1169
GYL Financial Synergies
Connecticut
$5.88M -$987K -6,634 -14%
SAM
1170
Smithbridge Asset Management
Pennsylvania
$5.87M -$768K -5,161 -11%
AFG
1171
Atomi Financial Group
New York
$5.86M +$442K +2,969 +8%
TCOT
1172
Trust Company of Toledo
Ohio
$5.83M +$426K +2,862 +8%
FNBTCON
1173
First National Bank & Trust Co of Newtown
Pennsylvania
$5.83M -$228K -1,533 -4%
OA
1174
Oxbow Advisors
Texas
$5.82M +$53.4K +359 +0.9%
AWM
1175
Avior Wealth Management
Nebraska
$5.81M -$635K -4,270 -10%

JNJ Hedge Fund Activity: Q2 2024 in Review

3,802 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2024, worth a combined $249B — down 6.2% from $266B a quarter earlier.

Buyers outnumbered sellers: 162 funds opened new JNJ positions and 154 closed out — a net gain of 8 holders — while 1,507 added to existing stakes and 1,791 trimmed.

The largest buyer was BlackRock, adding an estimated $1.26B. The largest seller was Capital International Investors, cutting an estimated $1.8B.

  • 3,802 institutional investors held Johnson & Johnson (JNJ) as of Q2 2024, down from 3,849 in Q1 2024.
  • Funds reported $249B of Johnson & Johnson stock for Q2 2024, down 6.2% quarter-over-quarter.
  • 162 funds opened new Johnson & Johnson positions in Q2 2024 and 154 closed out, a net change of +8 holders.
  • The largest Johnson & Johnson buyer in Q2 2024 was BlackRock, an estimated $1.26B added.
  • The largest Johnson & Johnson seller in Q2 2024 was Capital International Investors, an estimated $1.8B sold.

Based on aggregated 13F filings for Q2 2024.